Denosumab: the era of targeted therapies in bone metastatic diseases.
Santini D, Fratto ME, Vincenzi B, Napoli N, Galluzzo S, Tantardini M, Abbruzzese A, Caraglia M, Tonini G.
Santini D, et al. Among authors: fratto me.
Curr Cancer Drug Targets. 2009 Nov;9(7):834-42. doi: 10.2174/156800909789760375.
Curr Cancer Drug Targets. 2009.
PMID: 20025571
Review.